alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2022237EN.01006801.xml

| 20.6.2022 | EN | Official Journal of the European Union | C 237/68 |
| --- | --- | --- | --- |

20.6.2022

EN

Official Journal of the European Union

C 237/68

---

Action brought on 27 April 2022 — Casablanca Clothing v EUIPO — Adrien (CASABLANCA TENNIS CLUB)

(Case T-228/22)

(2022/C 237/88)

Language in which the application was lodged: French

Parties

Applicant: Casablanca Clothing Ltd (London, United Kingdom) (represented by: A. Cléry and C. Devernay, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Adrien SARL (Marseille, France)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant

Trade mark at issue: International registration designating the European Union in respect of the mark CASABLANCA TENNIS CLUB — International registration designating the European Union No 1 471 645

Proceedings before EUIPO: Invalidity proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 22 February 2022 in Case R 1186/2021-5

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | register the European part of the international mark CASABLANCA TENNIS CLUB No 1 471 645; |
| --- | --- |

—

register the European part of the international mark CASABLANCA TENNIS CLUB No 1 471 645;

| — | order EUIPO to pay the costs, including the costs before the Board of Appeal. |
| --- | --- |

—

order EUIPO to pay the costs, including the costs before the Board of Appeal.

Plea in law

Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---
Elijah A. BALL v. STATE of North Carolina.

No. 566P04.

Supreme Court of North Carolina.

March 3, 2005.

Elijah Alton Ball, Pro Se.

John G. Barnwell, Assistant Attorney General, C. Branson Vickory, III, District Attorney, for State of NC.

*ORDER*

Upon consideration of the notice of appeal from the North Carolina Court of Appeals, filed by Plaintiff on the 2nd day of November 2004 in this matter pursuant to G.S. 7A-30 (substantial constitutional question), the following order was entered and is hereby certified to the North Carolina Court of Appeals: the notice of appeal is

"Dismissed ex mero motu by order of the Court in conference, this the 3rd day of March 2005."

Upon consideration of the Request for Delayed Appeal filed on the 9th day of November 2004 by Plaintiff in this matter, the *170following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Dismissed by order of the Court in conference, this the 3rd day of March 2005."
EXHIBIT 31.1

                OFFICER'S CERTIFICATION PURSUANT TO SECTION 302

I,  Caroline  Rechia,  the  President,  Chief Executive Officer, Chief Financial
Officer  and  Principal  Accounting  Officer of PortaltoChina.com, Inc., certify
that:

1.  I  have  reviewed  this  quarterly report on Form 10-Q of PortaltoChina.com,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material  fact or omit to state a material fact necessary to make the statements
made,  in  light of the circumstances under which such statements were made, not
misleading  with  respect  to  the  period  covered  by  this  report;

3.  Based  on  my  knowledge,  the  financial  statements,  and  other financial
information included in this report, fairly present in all material respects the
financial  condition, results of operations and cash flows of the small business
issuer  as  of,  and  for,  the  periods  presented  in  this  report;

4.  I  am  responsible  for establishing and maintaining disclosure controls and
procedures  (as  defined  in  Exchange  Act  Rules  13a-14  and  15d-14) for the
registrant  and  I  have:

a)  designed  such  disclosure  controls  and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is  made  known  to  me by others within those entities, particularly during the
period  in  which  this  quarterly  report  is  being  prepared;

b)  evaluated  the  effectiveness  of  the  registrant's disclosure controls and
procedures  as  of  a  date  within  90  days  prior  to the filing date of this
quarterly  report  (the  "Evaluation  Date");  and

c) presented in this quarterly report our conclusions about the effectiveness of
the  disclosure  controls  and  procedures  based  on  my  evaluation  as of the
Evaluation  Date;

5.  I  have  disclosed, based on our most recent evaluation, to the registrant's
auditors  and the audit committee of registrant's board of directors (or persons
performing  the  equivalent  function):

a)  all significant deficiencies in the design or operation of internal controls
which  could  adversely  affect  the  registrant's  ability  to record, process,
summarize  and  report  financial  data and have identified for the registrant's
auditors  any  material  weaknesses  in  internal  controls;  and

b)  any  fraud,  whether  or  not  material,  that  involves management or other
employees  who  have  a  significant role in the registrant's internal controls.

6.  I  have  indicated  in  this quarterly report whether there were significant
changes in internal controls or in other factors that could significantly affect
internal controls subsequent to the date of my most recent evaluation, including
any  corrective  actions  with  regard  to significant deficiencies and material
weaknesses.

January 8, 2009



By /s/ Caroline Rechia
Caroline Rechia
President, Chief Executive Officer,
Chief Financial Officer and
Principal Accounting Officer
IN THE

TENTH COURT OF APPEALS

No. 10-20-00083-CR

LEON CORNELIOUS,

Appellant

v.

THE STATE OF TEXAS,

Appellee

From the 19th District Court

McLennan County, Texas

Trial Court No. 2019-1204-C1

MEMORANDUM OPINION

Leon Cornelious was convicted of evading arrest or detention with a vehicle and 

possession of a controlled substance with the intent to deliver and sentenced to 25 and 30 

years in prison, respectively. See TEX. PENAL CODE § 38.04; TEX. HEALTH & SAFETY CODE

§ 481.113. 

In one issue, Cornelius contends there is insufficient evidence to show he is the 

person convicted of offenses from another jurisdiction which were used to enhance his 

sentence. The State concedes error. We have reviewed the record and concur in the 
Cornelious v. State Page 2

parties’ assessment of the record. Specifically, there is insufficient evidence that the Leon 

Cornelius identified in the out-of-state judgments is the same Leon Cornelius who is the 

defendant/appellant in this proceeding. 

Accordingly, the trial court’s judgments are reversed, this proceeding is remanded 

to the trial court for a new trial on punishment only, and otherwise, the judgments are 

affirmed.

TOM GRAY

Chief Justice

Before Chief Justice Gray,

Justice Neill, and

Justice Johnson

Reversed and remanded

Opinion delivered May 5, 2021 

Do not publish 

[CRPM]
I 

110TH CONGRESS 

2D SESSION H. R. 4947 

To extend the duty suspension on Benzoic acid, 3,4,5-trihydroxy-, propyl 

ester. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 15, 2008 

Mr. DAVID DAVIS of Tennessee introduced the following bill; which was 

referred to the Committee on Ways and Means 

A BILL 

To extend the duty suspension on Benzoic acid, 3,4,5- 

trihydroxy-, propyl ester. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. BENZOIC ACID, 3,4,5-TRIHYDROXY-, PROPYL 

4 ESTER. 

5 (a) IN GENERAL.—Heading 9902.22.34 of the Har6 monized Tariff Schedule of the United States (relating to 

7 Benzoic acid, 3,4,5-trihydroxy-, propyl ester) is amended 

8 by striking ‘‘12/31/2009’’ and inserting ‘‘12/31/2011’’. 

9 (b) EFFECTIVE DATE.—The amendment made by 

10 subsection (a) applies with respect to goods entered, or 


smartinez on PRODPC61 with BILLS
2 

•HR 4947 IH

1 withdrawn from warehouse for consumption, on or after 

2 the date that is 15 days after the date of enactment of 

3 this Act. 

Æ 


smartinez on PRODPC61 with BILLS
**Exhibit 32.1**

 

PHARMACOPEIA DRUG DISCOVERY, INC.

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF2002

 

Inconnection with the Quarterly Report of Pharmacopeia Drug Discovery, Inc.(the Company) on Form 10-Q for the period ended March 31, 2006, as filedwith the Securities and Exchange Commission on the date hereof (the Report), I,Leslie J. Browne, Ph.D., President and Chief Executive Officer of the Company,hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.

 

 
| /s/ Leslie J. Browne, Ph.D.                |   |   |
|-------------------------------------------------|--------|--------|
| Leslie J. Browne, Ph.D.                         |   |
| President, Chief Executive Officer and Director |   |
| (Principal Executive Officer)                   |   |
| May 12, 2006                                    |   |

 

1

----
**EXHIBIT 32.1**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**

 

In connection with the filing of the Quarterly Reporton Form 10-Q (the “Report”) of InfoSonics Corporation (the “Company”) forthe period ended March 31, 2010, Joseph Ram, the Chief Executive Officerof the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) the Report fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934  (15 U.S.C. 78m or78o(d)); and

 

(2) the information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 
| Date: May 14, 2010 | /s/ JOSEPH  RAM                     |
|------------------------------|------------------------------------------|
|                         | Joseph  Ram,                             |
| * *                     | *Chief  Executive Officer and President* |

 

----
Exhibit








Exhibit 10.1
SECOND AMENDMENT TO ROPER TECHNOLOGIES, INC. 
DIRECTOR COMPENSATION PLAN 


This Second Amendment to the Roper Technologies, Inc. Director Compensation Plan (the “Plan”) is made effective on June 10, 2019.


		
	(1)
	The first sentence of Section 5.2 of the Plan shall be amended and restated in its entirety to read as follows:




“Certain Eligible Participants shall be paid a Supplemental Annual Cash Retainer for service as independent chair of the Board or chair of a committee of the Board during a Plan Year, payable at the same times as installments of the Base Annual Cash Retainer are paid (including any deferred payment date pursuant to Section 5.5).”


		
	(2)
	Schedule I of the Plan shall be deleted in its entirety and replaced with the following revised Schedule I:




SCHEDULE I
DIRECTOR COMPENSATION SCHEDULE


The following shall become effective as of June 10, 2019


Base Annual Cash Retainer (all Non-Employee Directors): $60,000


Supplemental Annual Cash Retainers:


Chair of Audit Committee: $5,000
Chair of Compensation Committee: $5,000
Chair of Nominating and Corporate Governance Committee: $5,000
Independent Chair of the Board: $175,000


At the beginning of each calendar year, a Non-Employee Director may elect to accept some or all of her/his cash retainer(s) in Stock.  The number of shares of Stock that equal the economic value of the portion of the cash retainer(s) elected to be received in Stock shall be calculated by using the weighted average closing price for the Stock over the fifteen trading days ending on the date of grant, which shall be the date that the Company pays the cash retainers to Non-Employee Directors. 


Meeting Fees:


There are no fees for Board meetings or committee meetings.


Annual RSUs: 
The number of RSUs that equal an economic value of $665,000 measured by using the weighted average closing price for the Stock over the fifteen trading days ending on the date of grant.


		
	(3)
	All other terms and conditions of the Plan shall remain in full force and effect.




	
	
	/S/ John K. Stipancich

	John K. Stipancich

	Corporate Secretary
# Official Journal C 39/2022

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 39 |
| | |
| English edition | Information and Notices | Volume 6526 January 2022 |

ISSN 1977-091X

Official Journal

of the European Union

C 39

English edition

Information and Notices

Volume 6526 January 2022

---

| Contents | page |
| --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2022/C 39/01 | Euro exchange rates — 25 January 2022 | 1 |

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2022/C 39/01

Euro exchange rates — 25 January 2022

1

---

| EN | |
| --- | --- |

EN
Miles Barton NICHOLS, Petitioner v. UNITED STATES

No. 19-6766

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
EXHIBIT 32.2  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the Quarterly Report of Ammex Gold Mining Corp.  (the "Company") on Form 10-Q for the period ended December 31, 2008,  as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.  3.  A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.    Date:  February 20,  2009                 By: /s/ Lucie Letellier ------------------------------ Lucie Letellier , CFO      A signed original of this written statement required by Section 906, or other  document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32



CERTIFICATION PURSUANT TO THE SARBANES-OXLEY ACT

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002





I, Abraham Pierce, President and Chief Executive Officer of Modena 3, Inc. (the Company) do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



1.  This Quarterly Report on 10QSB of the Company for the period ended April 30, 2005 as filed with the Securities and Exchange Commission (the report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.  The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: June 28, 2005



/s/ Abraham Pierce

_______________________



Abraham Pierce

President and Chief Executive Officer
STATE of North Carolina v. Kenneth Manzi KAGONYERA.

No. 13P04.

Supreme Court of North Carolina.

June 24, 2004.

Kenneth Kagonyera, Pro Se.

Amy C. Kunstling, Assistant Attorney General, Ronald L. Moore, District Attorney, for State.

***ORDER***

Upon consideration of the petition filed by Defendant on the 8th day of January 2004 in this matter for a writ of certiorari to review the decision of the North Carolina Court of Appeals, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

> "Denied by order of the Court in conference, this the 24th day of June 2004."
EXHIBIT 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly  Report of Ammex Gold Mining Corp.  (the "Company") on Form 10-Q for the period ended September 30, 2008  as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.  3.  A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.     Date:  November 17, 2008  By: /s/ W. Campbell Birge ----------------- W. Campbell Birge Chief Executive Officer
# L_2016238EN.01000701.xml

| 6.9.2016 | EN | Official Journal of the European Union | L 238/7 |
| --- | --- | --- | --- |

6.9.2016

EN

Official Journal of the European Union

L 238/7

---

Corrigendum to Commission Implementing Decision (EU) 2016/887 of 2 June 2016 amending Annex II to Decision 2007/777/EC as regards the list of third countries or parts thereof from which the introduction into the Union of meat products and treated stomachs, bladders and intestines is authorised

(
  Official Journal of the European Union L 148 of 4 June 2016
  )

On page 7, in the second sentence of recital 6:

for:

‘without vaccination’,

read:

‘with vaccination’.

---
Exhibit



EXHIBIT 10.4



May 3, 2019


Christian Boas 
Rue du Moulin 12, 1310 La Hulpe (Belgium)


Emile Boas 
Avenue du Beau Feuillage 1A, 1950 Kraainem (Belgium)


Dreda / Sylvie Boas 
Avenue E. Van Becelaere 103, 1170 Watermael-Boitsfort (Belgium)


RE: Amendment to the Agreement for the Sale and Purchase of Shares of S.R.I.F. NV


Dear Sir/Madam,
We refer to the agreement for the sale and purchase of the shares of S.R.I.F. NV among Christian Boas, Emile Boas, Dreda general partnership under Belgian law and Sylvie Boas (together, the “Sellers”), Spirit AeroSystems Belgium Holdings BVBA (the “Purchaser”) and Spirit AeroSystems Holdings, Inc. (together with the Purchaser, “Spirit”), as amended by the Letter Agreements dated March 19, 2019 and March 27, 2019 (the “Agreement”).  
As it is our understanding that the Parties desire to extend the Long Stop Date in order to provide additional time for the Competition Condition to be satisfied, we hereby seek the agreement of the Sellers to replace and restate the definition of Long Stop Date in the Agreement as follows:
“Long Stop Date means July 15, 2019;”
Additionally, in order to address capital expenditures budgeted by the Group Companies as of the Signing Date which have not been made prior to the Closing, the Parties hereby agree that no later than May 14, 2019, they will agree to amend the SPA to provide for certain minor administrative changes described on Exhibit A hereto.
The Parties acknowledge and agree that this letter agreement has been negotiated by the Parties in good faith.
This letter agreement constitutes a written agreement by and among the Parties as set forth in Clause 25.8 of the Agreement.
All terms used but not defined herein shall have the meaning set forth in the Agreement. Clause 26 of the Agreement shall apply also to this letter agreement.
Yours faithfully on behalf of Spirit,
/s/ Sam J. Marnick
Mrs. Sam. J. Marnick


















EXHIBIT 10.4



	
			
	For acknowledgement and acceptance,
On behalf of the Sellers:






/s/ Mr. Christian Boas
Mr. Christian Boas
Date: May 3, 2019


	 
	 






/s/ Mr. Emile Boas
Mr. Emile Boas
Date: May 3, 2019








/s/ Mrs. Sylvie Boas
Mrs. Sylvie Boas
Date: May 3, 2019








/s/ Mrs. Sylvie Boas
Dreda General Partnership
Mrs. Sylvie Boas
Director
Date: May 3, 2019










Cc: Eubelius CVBA
Marieke Wyckaert and Matthias Wauters 
Avenue Louise 99, 1050 Brussels (Belgium)
EXHIBIT 21.4



LIST OF SUBSIDIARIES



1.            Antek Wireless, Inc., a wholly-owned subsidiary of the Registrant, was incorporated in the State of Delaware on November 2, 1999.



2.            Emergent Technologies Corp. was incorporated in the State of West Virginia on September 29, 1995. The Registrant holds a 76.625% equity interest in Emergent.



3.            Integral Vision Systems Inc., a wholly owned subsidiary, was incorporated in the State of West Virginia on January 20, 1994. The Registrant acquired a 100% equity interest in Integral Vision in March 1997.



4.            ElectriPlast Corp., a wholly-owned subsidiary of the Registrant, was incorporated in the State of Delaware on February 16, 2001.



5.            Integral Technologies Asia, Inc. a wholly owned subsidiary of the registrant was incorporated in Asia on February 19, 2014.



6.            Integral Operating, Inc., a wholly owned subsidiary of the registrant was incorporated in Washington on December 10, 2013.

 

 



---

---